PCCM Hub
Back to Library
PleuralCurrent Guideline Must Read⚡ High-Yield Board Topic

BTS Pleural Disease Guideline 2010

Maskell N; British Thoracic Society Pleural Disease Guideline Group·Thorax·2010· DOI: 10.1136/thx.2010.136978
Pleural EffusionPleural DiseaseBTSGuidelinesThoracentesisEmpyemaPneumothorax
AI

AI-Generated Summary

Educational summary — always verify with primary source
Background

The BTS Pleural Disease Guideline 2010 is the definitive reference for pleural effusion evaluation, empyema management, and pneumothorax treatment in the UK and internationally.

Study Design

Evidence-based guideline by BTS Pleural Disease Guideline Group.

Key Findings

Key recommendations: (1) Light's criteria for exudate/transudate; (2) Pleural fluid pH <7.2 = complicated parapneumonic/empyema requiring drainage; (3) Ultrasound guidance for all thoracentesis; (4) Empyema: chest tube + intrapleural fibrinolytics (tPA/DNase); (5) Pneumothorax: size ≥2 cm or symptomatic = intervention; (6) Malignant effusion: indwelling pleural catheter (IPC) or pleurodesis.

Clinical Bottom Line

Know Light's criteria (protein >0.5, LDH >0.6, LDH >2/3 upper limit). pH <7.2 = drain the effusion. Ultrasound guidance is mandatory. For empyema, tPA + DNase (MIST2 trial) is superior to either alone.

Limitations & Caveats

Some recommendations based on low-quality evidence. Updated by 2023 BTS guideline for specific areas.

Faculty Notes— Dr. Andrew

Light's criteria must be memorized. pH <7.2 = drain. Know the BTS pneumothorax algorithm (size, symptoms, primary vs secondary).

Read Full Article

Access the complete publication on PubMed

Open PubMed

Send Feedback

Help us improve PCCM Hub

What kind of feedback do you have?